Richard A P Takx1,2, Megan H MacNabb1, Hamed Emami1, Amr Abdelbaky1, Parmanand Singh1,3, Zachary R Lavender1, Marcelo di Carli4, Viviany Taqueti4, Courtney Foster4, Jessica Mann5, Robert A Comley5, Chek Ing Kiu Weber5, Ahmed Tawakol6,7,8. 1. Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. 2. Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA. 4. Division of Radiology, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA. 5. F. Hoffmann-La Roche Ltd., Basel, Switzerland. 6. Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. atawakol@partners.org. 7. Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. atawakol@partners.org. 8. Massachusetts General Hospital, 165 Cambridge Street, Suite 400, Boston, MA, 02114-2750, USA. atawakol@partners.org.
Abstract
PURPOSE: While it is well known that patients with chronic kidney disease (CKD) are at increased risk for the development and progression of atherosclerosis, it is not known whether arterial inflammation is increased in mild CKD. The aim of this study was to compare arterial inflammation using 18F-FDG PET/CT in patients with CKD and in matched controls. METHODS: This restrospective study included 128 patients undergoing FDG PET/CT imaging for clinical indications, comprising 64 patients with stage 3 CKD and 64 control patients matched by age, gender, and cancer history. CKD was defined according to guidelines using a calculated glomerular filtration rate (eGFR). Arterial inflammation was measured in the ascending aorta as FDG uptake on PET. Background FDG uptake (venous, subcutaneous fat and muscle) were recorded. Coronary artery calcification (CAC) was assessed using the CT images. The impact of CKD on arterial inflammation and CAC was then assessed. RESULTS: Arterial inflammation was higher in patients with CKD than in matched controls (standardized uptake value, SUV: 2.41 ± 0.49 vs. 2.16 ± 0.43; p = 0.002). Arterial SUV correlated inversely with eGFR (r = -0.299, p = 0.001). Venous SUV was also significantly elevated in patients with CKD, while subcutaneous fat and muscle tissue SUVs did not differ between groups. Moreover, arterial SUV remained significantly elevated in patients with CKD compared to controls after correcting for muscle and fat background, and also remained significant after adjusting for clinical risk factors. Further, CKD was associated with arterial inflammation (SUV) independent of the presence of subclinical atherosclerosis (CAC). CONCLUSION: Moderate CKD is associated with increased arterial inflammation beyond that of controls. Further, the increased arterial inflammation is independent of presence of subclinical atherosclerosis. Current risk stratification tools may underestimate the presence of atherosclerosis in patients with CKD and thereby the risk of cardiovascular events.
PURPOSE: While it is well known that patients with chronic kidney disease (CKD) are at increased risk for the development and progression of atherosclerosis, it is not known whether arterial inflammation is increased in mild CKD. The aim of this study was to compare arterial inflammation using 18F-FDG PET/CT in patients with CKD and in matched controls. METHODS: This restrospective study included 128 patients undergoing FDG PET/CT imaging for clinical indications, comprising 64 patients with stage 3 CKD and 64 control patients matched by age, gender, and cancer history. CKD was defined according to guidelines using a calculated glomerular filtration rate (eGFR). Arterial inflammation was measured in the ascending aorta as FDG uptake on PET. Background FDG uptake (venous, subcutaneous fat and muscle) were recorded. Coronary artery calcification (CAC) was assessed using the CT images. The impact of CKD on arterial inflammation and CAC was then assessed. RESULTS:Arterial inflammation was higher in patients with CKD than in matched controls (standardized uptake value, SUV: 2.41 ± 0.49 vs. 2.16 ± 0.43; p = 0.002). Arterial SUV correlated inversely with eGFR (r = -0.299, p = 0.001). Venous SUV was also significantly elevated in patients with CKD, while subcutaneous fat and muscle tissue SUVs did not differ between groups. Moreover, arterial SUV remained significantly elevated in patients with CKD compared to controls after correcting for muscle and fat background, and also remained significant after adjusting for clinical risk factors. Further, CKD was associated with arterial inflammation (SUV) independent of the presence of subclinical atherosclerosis (CAC). CONCLUSION: Moderate CKD is associated with increased arterial inflammation beyond that of controls. Further, the increased arterial inflammation is independent of presence of subclinical atherosclerosis. Current risk stratification tools may underestimate the presence of atherosclerosis in patients with CKD and thereby the risk of cardiovascular events.
Authors: Andrew J Einstein; Lynne L Johnson; Sabahat Bokhari; Jessica Son; Randall C Thompson; Timothy M Bateman; Sean W Hayes; Daniel S Berman Journal: J Am Coll Cardiol Date: 2010-11-30 Impact factor: 24.094
Authors: James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad Journal: J Am Coll Cardiol Date: 2007-08-13 Impact factor: 24.094
Authors: Ahmed Tawakol; Zahi A Fayad; Robin Mogg; Achilles Alon; Michael T Klimas; Hayes Dansky; Sharath S Subramanian; Amr Abdelbaky; James H F Rudd; Michael E Farkouh; Irene O Nunes; Chan R Beals; Sudha S Shankar Journal: J Am Coll Cardiol Date: 2013-05-30 Impact factor: 24.094
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Christina L Fanola; Deirdre Mooney; Andrew J Cowan; Darae Ko; Emily K Sisson; Lori E Henault; Yorghos Tripodis; Elaine M Hylek Journal: Am Heart J Date: 2016-11-04 Impact factor: 4.749
Authors: Leandro Barbagelata; Walter Masson; Emiliano Rossi; Martin Lee; Juan Lagoria; Manuel Vilas; Rodolfo Pizarro; Guillermo Rosa Diez Journal: High Blood Press Cardiovasc Prev Date: 2022-06-25
Authors: Anne M Hüsing; Vera C Wulfmeyer; Svenja Gaedcke; Susanne V Fleig; Song Rong; David DeLuca; Hermann Haller; Roland Schmitt; Sibylle von Vietinghoff Journal: J Am Soc Nephrol Date: 2022-05-10 Impact factor: 14.978
Authors: Johannes Nordlohne; Alexandra Helmke; Shuwang Ge; Song Rong; Rongjun Chen; Ari Waisman; Hermann Haller; Sibylle von Vietinghoff Journal: JACC Basic Transl Sci Date: 2018-01-10
Authors: Ismaheel O Lawal; Akintunde T Orunmuyi; Gbenga O Popoola; Thabo Lengana; Kgomotso M G Mokoala; Alfred O Ankrah; Mike M Sathekge Journal: Medicine (Baltimore) Date: 2020-11-25 Impact factor: 1.889
Authors: Jordi Bover; Armando Aguilar; Carolt Arana; Pablo Molina; María Jesús Lloret; Jackson Ochoa; Gerson Berná; Yessica G Gutiérrez-Maza; Natacha Rodrigues; Luis D'Marco; José L Górriz Journal: Front Med (Lausanne) Date: 2021-05-19